Top

Diabetology & Metabolic Syndrome

Published in:

Open Access 01-12-2017 | Short report

Translation and cultural adaptation into Brazilian culture of type 1 diabetes distress scale

Authors: M. S. V. M. Silveira, T. G. Bovi, P. F. Oliveira, E. J. Pavin, L. Fisher

Published in: Diabetology & Metabolic Syndrome | Issue 1/2017

Abstract

Background

Diabetes related distress is common in type 1 diabetes patients (T1D). High levels of diabetes distress are related to poor metabolic control. An instrument to evaluate diabetes distress in T1D patients is “type 1 diabetes scale-T1DDS”. The aim of this study was to translate and culturally adapt the T1DDS into Brazilian culture.

Methods

T1DDS scale was translated into Portuguese. Back translation was performed and evaluated by a specialists committee. Pre-test was performed with 40 T1D outpatients at State University of Campinas hospital. Internal consistency, external consistency and re-test were performed.

Results

72% women, mean age: 32, 1 ± 9, 7 years, mean diabetes duration: 15, 8 ± 9, 1 years, mean scholarity: 11, 5 ± 3, 6, glycosylated hemoglobin mean: 9 ± 2%. Internal consistency: Cronbach alpha of T1DDS Brazilian version was 0.93. External consistency: Spearman’s coefficient between T1DDS and PAID, Brazilian version, was 0.7781; (p < 0.0001).

Conclusions

The T1DDS Brazilian version is a reliable tool to evaluate diabetes distress in T1D patients in the Brazilian Population. This tool can be useful in clinical care and to identify patiens at risk and in need for psychosocial intervention.

The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long- term complications in insulin-dependent diabetes melittus. N Engl J Med. 2003;329:977–85.

Berntein CM, Stockwell MS, Gallagher MP, Rosenthal SL, Soren K. Mental health issues in adolescents and young adults with type 1 diabetes. Prevalence and impact on glycemic control. Clin Pediatr. 2013;52(1):10–5.CrossRef

Strandberg RB, Grave M, Wentzel-Larsen T, Peyrot M, Rokne B. Relationships of diabetes-specific emotional distress, depression, anxiety and overall well-being with HbA1c in adult persons with type 1 diabetes. J Psychosom Res. 2014;77:174–9.CrossRefPubMed

Bot M, Pouwer F, De Gonge P, Tack CJ, Gulnod-Duijvestijn PHLM, Snoek FJ. Research: educational and psychological aspects-differential associations between depressive symptoms and glycaemic control in outpatients with diabetes. Diabet Med. 2012;30(3):115–21.CrossRef

Nicolucci A, Kovacs Burns K, Holt RIG, Comaschi M, Hermans N, Ishi H, Kokoszka A, Pouwer F, Skovlund SE, Stuckey H, Tarkun I, Vallis M, Wens J, Peyrot M, On behalf of the DAWN2 study group. Diabetes attitudes, wishes and needs second study(DAWN 2): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabet Med. 2013;30(7):767–77.CrossRefPubMed

Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control-a meta analytic review of the literature. Diabetes Care. 2000;23:934–42.CrossRefPubMed

Fisher L, Goncalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabet Med. 2014;31(7):764–72.CrossRefPubMedPubMedCentral

Bächle C, Lange K, Stahl-Pehe A, Castillo K, Holl RW, Giani G, Rosenbauer J. Associations between HbA1c and depressive symptoms in young adults with early-onset type1 diabetes. Psychoneuroendocrinology. 2015;55:48–58.CrossRefPubMed

Fisher L, et al. Depression vs diabetes distress in T2 diabetes. Diabetes Care. 2007;30:542–8.CrossRefPubMed

10.

Fisher L, Mullan JT, Aren P, Glasgow RE, Hessler D, Masharani V. Diabetes distress but not clinical depression or depressive symptoms is associated with glycaemic control in both cross-sectional and longitudinal analyses. Diabetes Care. 2010;33(1):23–8.CrossRefPubMed

11.

Fisher L, Hessler DM, Polonsky WH, Masharani U, Peters AL, Blumer I, Strycker LA. Prevalence of depression in type 1 diabetes and the problem of over-diagnosis. Diabet Med. 2015. doi:10.1111/dme.12973.

12.

Fisher L, Polonsky WH, Hessler DM, Masharani U, Blumer I, Peters AL, Strycker LA, Bowyer V. Understanding the sources of diabetes distress in adults with type 1 diabetes. J Diabetes Complicat. 2015;29(4):572–7.CrossRefPubMedPubMedCentral

13.

Balfe M, Doyle F, Smith D, Screenan S, Brugha R, Hevey D, Conroy R. What’s distressing about having type 1 diabetes? A qualitative study of young adult’s perspectives. BMC Endocr Disord. 2012;13:13–25.

14.

Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186–91.CrossRefPubMed

15.

Gross CC, Scain SF, Scheffel L, Gross JL, Hutz CS. Brazilian version of the problems areas in diabetes scale (B-PAID): validation and identification of individuals at hight risk for emotional distress. Diabetes Res Clin Pract. 2007;76:455–9.CrossRefPubMed

16.

Conover WJ. Practical nonparametric statistics. 3rd ed. New York: Wiley; 1999.

17.

Nunnally JC. Psychometric theory. 1st ed. New York: McGraw-Hill; 1967.

18.

The SAS system for windows (statistical analysis system), versão 9.4.2002–2008; SAS Institute Inc, Cary, NC, USA.

19.

Fisher L, Skaff MM, Mullan JT, Arean P, Mohr DC, Masharani U, et al. Clinical depression vs. distress among patients with type 2 diabetes: not just a question of semantics. Diabetes Care. 2007;30:542–8.CrossRefPubMed

20.

Fisher L, Hessler D, Naranjo D, Polonsky WH. AASAP: a program to increase recruitment and retention in clinical trials. Patient Educ Couns. 2012;86(3):372–7.CrossRefPubMed

21.

Gomes MB, et al. Prevalence of adults with type 1 diabetes who meet the goals of care in daily clinical practice: a nationwide multicenter study in Brazil. Diabetes Res Clin Pract. 2012;97:63–70.CrossRefPubMed

Title: Translation and cultural adaptation into Brazilian culture of type 1 diabetes distress scale
Authors: M. S. V. M. Silveira
T. G. Bovi
P. F. Oliveira
E. J. Pavin
L. Fisher
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: Diabetology & Metabolic Syndrome / Issue 1/2017
Electronic ISSN: 1758-5996
DOI: https://doi.org/10.1186/s13098-017-0260-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Translation and cultural adaptation into Brazilian culture of type 1 diabetes distress scale

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2017

Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center

Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?

Effects of pioglitazone therapy on blood parameters, weight and BMI: a meta-analysis

Association between aerobic capacity and the improvement in glycemic control after the exercise training in type 2 diabetes

Urinary podocyte-associated mRNA levels correlate with proximal tubule dysfunction in early diabetic nephropathy of type 2 diabetes mellitus

Neutrophil killing of Staphylococcus aureus in diabetes, obesity and metabolic syndrome: a prospective cellular surveillance study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page